Does somatostatin confer insulinostatic effects of neuromedin U in the rat pancreas?

Pancreas

Volumn 38, Issue 2, 2009, Pages 208-212

  Kaczmarek, Przemyslaw ^a   Malendowicz, Ludwik K ^b   Fabis, Marzena ^a,c   Ziolkowska, Agnieszka ^b   Pruszynska Oszmalek, Ewa ^a   Sassek, MacIej ^a   Wojciechowicz, Tatiana ^a   Szczepankiewicz, Dawid ^a   Andralojc, Karolina ^a   Szkudelski, Tomasz ^a   Strowski, Mathias Z ^d   Nowak, Krzysztof W ^a  

^a POZNA UNIVERSITY OF LIFE SCIENCES   (Poland)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Cyclosomatostatin; Neuromedin U; Pancreas; Rat; Somatostatin

Indexed keywords

CYCLOSOMATOSTATIN; GLUCOSE; NEUROMEDIN U; SOMATOSTATIN; SOMATOSTATIN RECEPTOR; UNCLASSIFIED DRUG; INSULIN; NEUROMEDIN U RECEPTOR; NEUROPEPTIDE; NEUROTRANSMITTER RECEPTOR;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HORMONE RELEASE; IMMUNOHISTOCHEMISTRY; INSULIN RELEASE; INSULIN RESPONSE; NONHUMAN; PANCREAS; PANCREAS ISLET; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOIMMUNOASSAY; RAT; ANIMAL; DRUG EFFECT; PHYSIOLOGY; SECRETION; WISTAR RAT;

ANIMALS; INSULIN; NEUROPEPTIDES; PANCREAS; RATS; RATS, WISTAR; RECEPTORS, NEUROTRANSMITTER; SOMATOSTATIN;

EID: 65349132958     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPA.0b013e31818d9095     Document Type: Article

References (20)

1. Minamino N, Kangawa K, Matsuo H. Neuromedin U-8 and U-25: novel uterus stimulating and hypertensive peptides identified in porcine spinal cord. Biochem Biophys Res Commun. 1985;130:1078-1085.
2. Domin J, Ghatei MA, Chohan P, et al. Neuromedin UVa study of its distribution in the rat. Peptides. 1987;8:779-784.
3. Murphy R, Turner CA, Furness JB, et al. Isolation and microsequence analysis of a novel form of neuromedin U from guinea pig small intestine. Peptides. 1990;11:613-617.
4. O'Harte F, Bockman CS, Abel PW, et al. Isolation, structural characterization and pharmacological activity of dog neuromedin U. Peptides. 1991;12:11-15.
5. Kage R, O'Harte F, Thim L, et al. Rabbit neuromedin U-25: lack of conservation of a posttranslational processing site. Regul Pept. 1991;33:191-198.
6. Salmon AL, Johnsen AH, Bienert M, et al. Isolation, structural characterization, and bioactivity of a novel neuromedin U analog from the defensive skin secretion of the Australasian tree frog, Litoria caerulea. J Biol Chem. 2000;275:4549-4554.
7. Szekeres PG, Muir AI, Spinage LD, et al. Neuromedin U is a potent agonist at the orphan G protein-scoupled receptor FM3. J Biol Chem. 2000;275:20247-20250.
8. Hedrick JA, Morse K, Shan L, et al. Identification of a human gastrointestinal tract and immune system receptor for the peptide neuromedin U. Mol Pharmacol. 2000;58:870-875.
9. Fujii R, Hosoya M, Fukusumi S, et al. Identification of neuromedin U as the cognate ligand of the orphan G protein-coupled receptor FM-3. J Biol Chem. 2000;275:21068-21074.
10. Nakazato M, Hanada R, Murakami N, et al. Central effects of neuromedin U in the regulation of energy homeostasis. Biochem Biophys Res Commun. 2000;277:191-194.
11. Hanada R, Teranishi H, Pearson JT, et al. Neuromedin U has a novel anorexigenic effect independent of the leptin signaling pathway. Nat Med. 2004;10:1067-1073.
12. Howard AD, Wang R, Pong SS, et al. Identification of receptors for neuromedin U and its role in feeding. Nature. 2000;406:70-74.
13. Jethwa PH, Small CJ, Smith KL, et al. Neuromedin U has a physiological role in the regulation of food intake and partially mediates the effects of leptin. Am J Physiol Endocrinol Metab. 2005;289:E301-E305.
14. Raddatz R, Wilson AE, Artymyshyn R, et al. Identification and characterization of two neuromedin U receptors differentially expressed in peripheral tissues and the central nervous system. J Biol Chem. 2000;275:32452-32459.
15. Kaczmarek P, Malendowicz LK, Pruszynska-Oszmalek E, et al. Neuromedin U receptor 1 expression in the rat endocrine pancreas and evidence suggesting neuromedin U suppressive effect on insulin secretion from isolated rat pancreatic islets. Int J Mol Med. 2006; 18(5):951-955.
16. Fabis M, Pruszynska E, Mackowiak P. In vivo and in situ action of melatonin on insulin secretion and some metabolic implications in the rat. Pancreas. 2002;25:166-169.
17. Lacy PE, Kostianovsky M. Method for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes. 1967;16:35-39.
18. Kahn BB, Flier JS. Obesity and insulin resistance. J Clin Invest. 2000;106:473-481.
19. Lustig RH, Sen S, Soberman JE, et al. Obesity, leptin resistance, and the effects of insulin reduction. Int J Obes Relat Metab Disord. 2004; 28:1344-1348.
20. Sharp GW. Mechanisms of inhibition of insulin release. Am J Physiol Cell Physiol. 1996;271:C1781-C1799.